The Traderszone Network

28 September, 2016 by The TZ Newswire Staff Comments Off on Eurostoxx 50 futures up 1.1% in early European trading

Eurostoxx 50 futures up 1.1% in early European trading

Positive OPEC-led moves as we wait on the official openings 29 Sept
– DAX futures +1.1%
– CAC40 +1.2%
– FTSE +1.1%
Bund futures down 43 at 165.72

28 September, 2016 by The TZ Newswire Staff Comments Off on Asia Markets: Energy-related stocks help rally Asia markets as investors cheer OPEC deal

Asia Markets: Energy-related stocks help rally Asia markets as investors cheer OPEC deal

A deal agreed by major oil producers to cut output triggers a rally for Asian stocks as oil-related stocks lead the charge higher.
read more

28 September, 2016 by The TZ Newswire Staff Comments Off on Nikkei 225 closes up +1.39% at 16,693.71

Nikkei 225 closes up +1.39% at 16,693.71

A good day for Japanese equities as energy companies rise on OPEC deal
– +228.31
– open 16606.30
– high 16756.43
– low 16584.14
– USDJPY 101.63 despite the Nikkei fading into the close

28 September, 2016 by The TZ Newswire Staff Comments Off on Supercars, SUVs and future tech: What to watch for at the Paris Motor Show

Supercars, SUVs and future tech: What to watch for at the Paris Motor Show

The Paris Motor Show will see many of the largest companies in the autos industry exhibiting their latest models and technology.

28 September, 2016 by The TZ Newswire Staff Comments Off on Currencies: Yen pulls back, dollar higher as investor appetite for risk heats up

Currencies: Yen pulls back, dollar higher as investor appetite for risk heats up

A rally for oil prices and U.S.

read more

28 September, 2016 by The TZ Newswire Staff Comments Off on Deinove : 2016 interim results: Stability of net loss Strategic refocusing on carotenoids and antibiotics

Deinove : 2016 interim results: Stability of net loss Strategic refocusing on carotenoids and antibiotics

28 September, 2016 by The TZ Newswire Staff Comments Off on MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis

MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis